A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

Conditions: Prostate Cancer; Radical Prostatectomy Interventions: Drug: REGN5678; Drug: Piflufolastat F18 Sponsors: M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials